Astrazeneca Plc (AZN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AZN.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
AZN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AZN as an investment opportunity.
- Astrazeneca Plc's number of analysts covering the stock is greater than 94.76% of all US stocks.
- AZN has a lower percent of analysts bearish on the stock than 10.88% of Pharmaceutical Products stocks.
- AZN has a higher average analyst price target than 84.62% of Pharmaceutical Products stocks.
- Astrazeneca Plc's upside potential (average analyst target price relative to current price) is greater than 16.78% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of AZN is lower than 20.96% of all US stocks.
- AZN has a greater percentage of analysts bullish on the stock than 28.24% of Pharmaceutical Products stocks.
- AZN has a lower change in bullishness amongst analysts than just about 100% of all US stocks.
What is the outlook for AZN? Use POWR Ratings for clearer insight into price direction.